Enterovirus 71 vaccine: When will it be available?

Journal of the Formosan Medical Association

Volumn 110, Issue 7, 2011, Pages 425-427

  Huang, Mei Liang ^a   Ho, Mei Shang ^b   Lee, Min Shi ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROVIRUS 71 VACCINE; NEUTRALIZING ANTIBODY; POLIOMYELITIS VACCINE; PROTEIN VP1; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANTIBODY RESPONSE; ANTIGENICITY; CONVALESCENCE; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG EFFICACY; ENCEPHALITIS; ENTEROVIRUS 71; ENTEROVIRUS 71 INFECTION; ENTEROVIRUS INFECTION; EPIDEMIC; FEASIBILITY STUDY; GENOME ANALYSIS; GENOTYPE; HAND FOOT AND MOUTH DISEASE; HERPANGINA; HIGH RISK POPULATION; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; MYELITIS; NOTE; PHASE 1 CLINICAL TRIAL (TOPIC); PHYLOGENY; POSTMARKETING SURVEILLANCE; RETROSPECTIVE STUDY; RISK REDUCTION; TAIWAN; VACCINATION; VIRUS CAPSID; VIRUS CLASSIFICATION; VIRUS GENOME; VIRUS ISOLATION; VIRUS RECOMBINATION;

EID: 79960755929     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(11)60063-6     Document Type: Note

References (10)

1. van der Sanden S, Koopmans M, Uslu G, et al. Epidemiology of Enterovirus 71 in the Netherlands, 1963-2008. J Clin Microbiol 2009;47:2826-33.
2. Tee KK, Lam TT, Chan YF, et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol 2010;84:3339-50.
3. Lee MS, Chang LY. Development of enterovirus 71 vaccines. Expert Rev Vaccines 2010;9:149-56.
4. Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010;10:778-90.
5. Wood DJ, Heath AB, Kersten GF, et al. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine. Biologicals 1997;25:59-64.
6. Wood DJ, Heath AB, Sawyer LA. A WHO Collaborative study on assays of the antigenic content of inactivated poliovirus vaccines. Biologicals 1995;23:83-94.
7. Huang SW, Hsu YW, Smith DJ, et al. Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol 2009;47:3653-62.
8. Lee MS, Lin TY, Chiang PS, et al. An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr Infect Dis J 2010; 29:1030-4.
9. Huang YP, Lin TL, Hsu LC, et al. Genetic diversity and C2-like subgenogroup strains of enterovirus 71, Taiwan, 2008. Virol J 2010;7:277.
10. Yu H, Chen W, Chang H, et al. Genetic analysis of the VP1 region of enterovirus 71 reveals the emergence of genotype A in central China in 2008. Virus Genes 2010; 41:1-4.